1. Home
  2. HCWB vs FTEL Comparison

HCWB vs FTEL Comparison

Compare HCWB & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HCW Biologics Inc.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$1.36

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Logo Fitell Corporation

FTEL

Fitell Corporation

HOLD

Current Price

$3.28

Market Cap

3.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCWB
FTEL
Founded
2018
2007
Country
United States
Australia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
3.7M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
HCWB
FTEL
Price
$1.36
$3.28
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$35.00
N/A
AVG Volume (30 Days)
56.3K
335.7K
Earning Date
11-14-2025
11-17-2025
Dividend Yield
N/A
48.93%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$422,026.00
$5,200,138.00
Revenue This Year
$178.64
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.42
52 Week Low
$0.95
$2.91
52 Week High
$41.20
$1,427.20

Technical Indicators

Market Signals
Indicator
HCWB
FTEL
Relative Strength Index (RSI) 44.27 73.02
Support Level $1.10 $3.01
Resistance Level $1.35 $3.50
Average True Range (ATR) 0.13 0.22
MACD 0.06 0.27
Stochastic Oscillator 89.07 83.36

Price Performance

Historical Comparison
HCWB
FTEL

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

About FTEL Fitell Corporation

Fitell Corp conducts its primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiary, serving personal training studios and commercial gyms. Its product coverage includes four proprietary brands: Muscle Motion for strength-training equipment, Rapid Motion with a focus on commercial items, FleetX for cardio equipment, and Harison for cardio, strength, recovery, and conditioning products. The Company operates in one segment, trading gym equipment, and also provides licensing services and gym equipment to overseas gym studios. Majority of its business is conducted in Australia via its e-commerce platform and third-party sites, with maximum revenue earned from retail.

Share on Social Networks: